These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28490409)

  • 1. Endoscopic-guided coblation treatment of nasal telangiectasias in hereditary hemorrhagic telangiectasia: "How I do it".
    Poetker DM
    Am J Rhinol Allergy; 2017 May; 31(3):205-206. PubMed ID: 28490409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of effectiveness of coblation for recurrent epistaxis in hereditary hemorrhagic telangiectasia.
    Feller CN; Adams JA; Friedland DR; Poetker DM
    Am J Otolaryngol; 2022; 43(3):103409. PubMed ID: 35216850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Practice Guideline: Nosebleed (Epistaxis).
    Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
    Otolaryngol Head Neck Surg; 2020 Jan; 162(1_suppl):S1-S38. PubMed ID: 31910111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization.
    Khanwalkar AR; Rathor A; Read AK; Paknezhad H; Ma Y; Hwang PH
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):1034-1042. PubMed ID: 34989143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.
    Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
    Otolaryngol Head Neck Surg; 2020 Jan; 162(1):8-25. PubMed ID: 31910122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe refractory epistaxis in hereditary hemorrhagic telangiectasia using a two-flap nasal closure method.
    Timmins BH; Hunter BN; Wilson KF; Ward PD
    Int Forum Allergy Rhinol; 2016 May; 6(5):544-8. PubMed ID: 26751606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
    Parambil JG; Woodard TD; Koc ON
    Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Luk L; Mace JC; Bhandarkar ND; Sautter NB
    Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation for treatment of hereditary hemorrhagic telangiectasia lesions: "How I do it".
    Rotenberg B; Noyek S; Chin CJ
    Am J Rhinol Allergy; 2015; 29(3):226-7. PubMed ID: 25975256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of endoscopic endonasal underwater surgery using a combination of coblation and a lens-cleaning system for hemostasis in hereditary hemorrhagic telangiectasia.
    Sakaida H; Kobayashi M; Takeuchi K
    Auris Nasus Larynx; 2024 Jun; 51(3):512-516. PubMed ID: 38522355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress of bevacizumab in the treatment of refractory epistaxis caused by hereditary hemorrhagic telangiectasia].
    Xu C; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):476-9. PubMed ID: 27345893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
    Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
    Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.
    Simonds J; Miller F; Mandel J; Davidson TM
    Laryngoscope; 2009 May; 119(5):988-92. PubMed ID: 19194865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.
    Ghaheri BA; Fong KJ; Hwang PH
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1006-9. PubMed ID: 16730547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia.
    Choi JW; Joo YH; Jeong WS; Jang YJ
    Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Pain Following Coblation of Sinonasal Hereditary Hemorrhagic Telangiectasias.
    Kraimer K; Scott B; Farrell N; Geltzeiler M; Smith T; Detwiller K
    Ann Otol Rhinol Laryngol; 2024 Jan; 133(1):58-62. PubMed ID: 37377016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of bevacizumab and cyanoacrylate glue for hereditary hemorrhagic telangiectasia.
    Khoueir N; Borsik M; Camous D; Herman P; Verillaud B
    Laryngoscope; 2019 Oct; 129(10):2210-2215. PubMed ID: 31566760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review.
    Kini SD; Yiu DW; Weisberg RA; Davila JF; Chelius DC
    Ann Otol Rhinol Laryngol; 2019 May; 128(5):467-471. PubMed ID: 30693788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.